1. Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

    Ariette van Strien, Chief Commercial Officer and Daniel Bell, Vice President, Regulatory Compliance & Technical Affairs at Marken, discuss clinical trial logistics without boundaries. 

  2. Cultivating a Proactive Quality Culture

    Phillippe Dartiguelongue, Industry Quality Director at Servier CDMO explains how emphasis on quality mitigates patient risk.

  3. Five Critical Considerations for Pharmaceutical M&A

    Merger and acquisition (M&A) activity is deeply embedded into the culture of the pharmaceutical industry, here's what to keep in mind. 

  4. Supporting the Pharma Industry Small Business Growth Engine

    Syed T. Husain, Chief Commercial Officer and Catherine Hanley, Head of Marketing & Corporate Communications at Alcami explain how CDMOs can help bolster smaller players in pharma.

  5. Antibody-Drug Conjugate: Do We Understand The Capital Investment In Our Staff?
    Industry experts weigh in on our Roundtable question. 
  6. Designing Effective Drug Formulations: Keys to Successful Proof of Concept Services

    Ed Scholtz, Ph.D., Vice President of R&D for UPM Pharmaceuticals explains the company's approach to formulations. 

  7. AMPAC Fine Chemicals to Be Acquired By SK Holdings

    This acquisition is the largest M&A transaction announced in the Korean pharmaceutical industry.

  8. New Antibiotic to be Tested against Potential Bioweapons
    US government agencies funding investigation of Spero Therapeutics’ SPR994 antibiotic.
  9. FDA Committee Gives Nod to New Treatment for Plasmodium Vivax Malaria

    Drug developed by GSK in collaboration with Medicines for Malaria Venture if approved would be first single-dose treatment for prevention of relapse.

  10. Upsher-Smith Launches Vigabatrin for Oral Solution Under The Brand Name Vigadrone™

    Vigadrone™ (vigabatrin) for Oral Solution, 500 mg is a fully substitutable, AA-rated generic version of Sabril®(vigabatrin) powder for oral solution.

  11. Achieving Controlled Nucleation During Aseptic Lyophilization

    Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency, says Robert Darrington, VP, Technical Marketing, SP Industries, Inc.

  12. Keys to Cultural Integration

    That’s Nice sat down with Catherine Hanley, Alcami’s Director of Marketing, to find out how to successfully integrate after a merger.

  13. Leveraging Hot Melt Extrusion for Solubility and Continuous Manufacturing

    Hot melt extrusion (HME) technology has become a key solution to adding absorption for enhanced solubility, says Tony Listro, Vice President, Technical Business Development at Foster Delivery Science.

  14. Becoming Bioavailable

    Poorly soluble molecules in the pipeline can have a negative effect on your active pharmaceutical ingredient (API).

  15. Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
    Clint Pepper, Ph.D., Director of MAST Technology at Capsugel, explains the Modular Automated Sampling Technology platform.
  16. What are the Greatest Challenges Drug Manufacturers Face When Working to Meet the New Requirements for Excipient Supply Chain Security?

    Industry experts weigh in on our Roundtable question.

  17. AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

    The US Food and Drug Administration (FDA) has granted venetoclax two Breakthrough Therapy Designations (BTDs) in AML, which are designed to expedite the development and review of medicines that are intended to treat a serious condition.

  18. New Treatment for Excessive Sweating Gets FDA Approval

    Demira’s awareness campaign for Qbrexa is drawing significant interest.

  19. Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

    The next-generation MitraClip system provides cardiologists with advanced steering, navigation, and positioning capabilities for the clip, making it easier to use in difficult anatomies. 

  20. Women’s Health Company to Expand

    Scottish company DYSUS Medical raises $25 million from Lundbeckfonden Ventures.


View All

Road To BIO: Coming Soon To Your Screen Q4 2018
The Road to BIO in Review
The Road To BIO: Day 12 California
The Road To BIO: Day 11 Arizona /// California
The Road To BIO: Day 10 Texas /// Arizona
The Road To BIO: Day 9 Texas
The Road To BIO: Day 8 Texas
The Road To BIO: Day 7 Mississippi /// Texas
The Road To BIO: Day 6 Georgia /// Mississippi
The Road To BIO: Day 5 South Carolina /// Georgia
The Road To BIO: Day 4 Tennessee /// South Carolina
The Road To BIO: Day 3 Pennsylvania /// Tennessee
The Road To BIO: Day 2 New York /// Pennsylvania
For Your Listening Pleasure
The full story of this epic journey can be experienced as an audiobook. Listen to the story behind the story – the characters, the challenges, and all 12 days of the Road To BIO.
Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
Drug Development

Appeals Board Rules in Favor of Novartis and its Multiple Sclerosis Drug Gilenya

Jul 18, 2018 11:52:08 AM PAO-M07-18-NI-014

Safety Concerns Raised about Valsartan from China

Jul 18, 2018 11:46:26 AM PAO-M07-18-NI-013
FDA Approval

Xtandi Gets FDA Second Cancer Therapy Approval

Jul 18, 2018 11:42:55 AM PAO-M07-18-NI-012
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

Jul 18, 2018 11:35:35 AM PAO-M07-18-NI-011

FDA Committee Gives Nod to New Treatment for Plasmodium Vivax Malaria

Jul 17, 2018 2:16:02 PM PAO-M07-18-NI-010
Drug Development

New Antibiotic to be Tested against Potential Bioweapons

Jul 17, 2018 2:12:46 PM PAO-M07-18-NI-009

Digital Ad Spending by Pharma is Growing Slowly

Jul 13, 2018 11:40:21 AM PAO-M07-18-NI-008
FDA Approval

New Treatment for Excessive Sweating Gets FDA Approval

Jul 13, 2018 11:29:42 AM PAO-M07-18-NI-008

Women’s Health Company to Expand

Jul 13, 2018 11:25:25 AM PAO-M07-18-NI-007
Clinical Research

Eating Well Might Improve Cancer Treatments

Jul 12, 2018 2:59:14 PM PAO-M07-18-NI-006

Organ-on-a-Chip Company Raises $36 Million

Jul 12, 2018 2:54:35 PM PAO-M07-18-NI-005

Bosch Packaging Business Up for Sale

Jul 10, 2018 11:06:51 AM PAO-M07-18-NI-004

Gottlieb Discusses Results of Online Opioid Summit

Jul 10, 2018 11:04:07 AM PAO-M07-18-NI-003

Alcon Set Out On its Own

Jul 10, 2018 10:59:59 AM PAO-M07-18-NI-002

Japan Approves Two New AstraZeneca Cancer Meds

Jul 10, 2018 10:24:44 AM PAO-M07-18-NI-001

Nice Insight Overview

Changes in the  Biopharma Industry: from Minor to Major Evolution
New technologies such as gene editing are leading to the development of even more advanced, targeted medicines.

The Next-Generation Player

Addressing Development Challenges for Complex Biologic Drug Candidates
At Lonza, we are constantly looking to reduce the development timeline, giving our customers more control over their projects.

Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing Lonza Pharma & Biotech

M+A Column

Inside Mergers & Acquisitions
Kevin Bottomley Partner, Results Healthcare
Deals in the pharmaceutical industry are an important mechanism of acquiring innovation, business and efficiency.

Nice Insight Overview

Doping: Famous Cases, Substances and Values in Sports

Marc Technow, Nice Insight